Drug Price Lookup
Live pharmacy acquisition cost (CMS NADAC) for any US drug — by strength, with effective dates.
Roflumilast (brands: Daliresp, ZORYVE)
| Strength | Acquisition cost | Effective |
|---|---|---|
| 0.15% Cream | $15.3955/unit | 10/21/2026 |
| 0.3% Foam | $15.3803/unit | 10/21/2026 |
| 250 MCG Tablet | $1.8047/unit | 10/21/2026 |
| 500 MCG Tablet | $0.3025/unit | 10/21/2026 |
Full profile — coverage, spending, alternatives: rxfinder.ai/drug/roflumilast
NADAC is what pharmacies actually pay to acquire the drug — the honest baseline for judging what a plan is charged.
Data: CMS NADAC (National Average Drug Acquisition Cost) — NADAC effective 10/21/2026 · source
Machine access — this tool is available as structured data for AI assistants and agents:
GET https://rxfinder.ai/tools/drug-price/data.json?drug=roflumilast